Venture Capital Investors

Translational Development Acquisition

Translational Development Acquisition is a venture capital firm that provides funding to technology-based companies.

Venture Investor Overview

Contact Information

Background Information

Overview

Translational Development Acquisition Corp has entered into a definitive agreement for a business combination with ProLogium, providing the capital to scale the mass production of ProLogium's 4th-generation superfluidized inorganic solid-state batteries, advance the construction of their Dunkirk gigafactory, and expand into high-growth markets including AI data centers, aerospace, robotics, and EVs. Expected close H2 2026, subject to regulatory and shareholder approvals. We are a generalist Special Purpose Acquisition Corporation managed by Stone Capital Partners. We seek to identify a great private business that would benefit from access to the public capital markets and our management's experience and expertise.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

7/28/2026

Transaction History

Our records indicate that Translational Development Acquisition invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

Title

Name

Email & Social

Chief Executive Officer

Michael Hoffman

        

Funds

No fund closings have been recorded for this company.

Portfolio Companies

Translational Development Acquisition has invested in only one tech company, according to our database records. If we are missing a portfolio company, please let us know.

Browse more venture capital investors:

Transitions First | Translink Capital

Share this article

About Our VC Investors Database

This VC firm profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary